help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2007-0024
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a related Letter to the Editor
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coutant, R.
Right arrow Articles by Morel, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coutant, R.
Right arrow Articles by Morel, Y.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Male Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 8 2868-2873
Copyright © 2007 by The Endocrine Society


CLINICAL CASE SEMINAR

Heterozygous Mutation of Steroidogenic Factor-1 in 46,XY Subjects May Mimic Partial Androgen Insensitivity Syndrome

Régis Coutant1, Delphine Mallet1, Najiba Lahlou, Natacha Bouhours-Nouet, Agnès Guichet, Lionel Coupris, Anne Croué and Yves Morel

Pediatric Endocrinology Department and Centre of Reference for Pathologies in Hormonal Receptivity (R.C., N.B.-N.), and Departments of Genetics (A.G.), Pediatric Surgery (L.C.), and Pathology (A.C.), University Hospital, 49033 Angers, France; Molecular Biology and Hormonology Department (D.M., Y.M.), Debrousse Hospital, 69000 Lyon, France; and Department of Pediatric Hormonology and Metabolic Diseases (N.L.), Saint Vincent de Paul Hospital, 75014 Paris, France

Address all correspondence and requests for reprints to: Régis Coutant, Department of Pediatric Endocrinology, University Hospital, 4 rue Larrey, 49033 Angers CEDEX 01, France. E-mail: recoutant{at}chu-angers.fr.

Context: The clinical and biological features of Sertoli cell and Leydig cell dysfunction are usually investigated when characterizing disorders of sex development in 46,XY individuals: This allows gonadal dysgenesis, a defective development of the gonad, to be distinguished from defects restricted to androgen synthesis or sensitivity. In humans, mutations in steroidogenic factor-1 (SF-1), one of the critical factors involved in testis development, have been reported to cause gonadal dysgenesis with or without adrenal failure in 46,XY individuals.

Objective: We report a SF-1 mutation that caused ambiguous genitalia associated with strikingly different hormonal phenotypes in two affected 46,XY children from the same family.

Methods: Hormonal evaluation included testosterone (T), anti-Mullerian hormone (AMH), inhibin B, FSH, and LH measurements during the first weeks of life, a period when physiological activation of the gonadotropin-gonadal system occurs. Direct DNA sequencing of the coding sequence of the SF-1 and the androgen receptor (AR) genes was performed.

Results: Both 46,XY children had ambiguous genitalia with no Mullerian structures and no adrenal insufficiency. The older child showed normal elevation of T (up to 7.6 nmol/liter, 2.2 ng/ml), AMH (504 pmol/liter, 70.6 ng/ml), inhibin B (245 pg/ml), FSH, and LH during the first weeks, which led to a presumptive diagnosis of partial androgen insensitivity syndrome. The AR sequence was, however, normal. In the second child, T, AMH, and inhibin B were low, suggesting gonadal dysgenesis. In both children and their mother, a c.536delC frameshift mutation in the SF-1 gene was found. This mutation terminates translation at position 295, removing the ligand-binding domain and the activation function 2 (AF-2) domain, a critical domain for SF-1 transactivating activity.

Conclusions: The usual markers of testis dysgenesis may be normal in 46,XY individuals with SF-1 mutation. Screening for SF-1 mutation should be performed in subjects with apparent partial androgen insensitivity syndrome and no mutation in the AR gene.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
B. Kohler, L. Lin, I. Mazen, C. Cetindag, H. Biebermann, I. Akkurt, R. Rossi, O. Hiort, A. Gruters, and J. C Achermann
The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency
Eur. J. Endocrinol., August 1, 2009; 161(2): 237 - 242.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. Lourenco, R. Brauner, L. Lin, A. De Perdigo, G. Weryha, M. Muresan, R. Boudjenah, G. Guerra-Junior, A. T. Maciel-Guerra, J. C. Achermann, et al.
Mutations in NR5A1 Associated with Ovarian Insufficiency
N. Engl. J. Med., March 19, 2009; 360(12): 1200 - 1210.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Pelusi, Y. Ikeda, M. Zubair, and K. L. Parker
Impaired Follicle Development and Infertility in Female Mice Lacking Steroidogenic Factor 1 in Ovarian Granulosa Cells
Biol Reprod, December 1, 2008; 79(6): 1074 - 1083.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Interpretation of chromatogram in Figure 2A
Eric J Lambie, et al.
JCEM Online, 31 Jan 2008 [Full text]
Author's Response to Letter
Yves Morel, et al.
JCEM Online, 31 Jan 2008 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society